Related Experiment Video
Updated: Feb 25, 2026
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Role of anti-receptor autoantibodies in pathophysiology of scleroderma
Melvin Berger1, Virginia D Steen2
1CSL Behring, King of Prussia, PA, USA..
Abstract:
The pathophysiology of SSc-mediated organ damage is complex and not well understood. Hallmarks of the disease include skin thickening, vasculopathy and gastrointestinal dysmotility. Diverse anti-nuclear antibodies can be used as biomarkers for classification and prognosis, but their role in producing tissue pathology/organ dysfunction is not established. In contrast, antibodies against cell surface receptors for platelet derived growth factor, angiotensin II, endothelin A, ICAM-1, and type 3 muscarinic acetyl choline receptors may play a major role in skin thickening, vasoconstriction/pulmonary and renal hypertension, ischemia and gastrointestinal dysmotility, respectively. In addition, antibodies to an inhibitory B-lymphocyte surface molecule, CD 22, may allow increased production of other autoantibodies. Each of these types of antibodies have been reported in some SSc patients, and laboratory studies suggest signaling pathways and mechanisms by which they may contribute to disease activity. However, we are far from a consensus on their importance. Additional epidemiologic, mechanistic and physiologic studies are needed. Confirmation of the roles of anti-receptor antibodies and identification of the signaling pathways by which they alter cellular functions would have major implications for treatment of SSc, both in terms of targeting autoantibodies and the cells that produce them, and in the use of small molecules which inhibit their pernicious effects.
Insights
Investigating scleroderma (SSc) pathophysiology reveals that antibodies targeting cell surface receptors, not just anti-nuclear antibodies, may drive organ damage. Further research is crucial for developing targeted SSc treatments.
Area of Science:
- Immunology
- Rheumatology
- Pathophysiology
Background:
- Scleroderma (SSc) pathophysiology involves complex mechanisms leading to organ damage, including skin thickening, vasculopathy, and gastrointestinal issues.
- While anti-nuclear antibodies are biomarkers, their direct role in SSc pathology is unclear.
- Antibodies targeting specific cell surface receptors are implicated in SSc manifestations.
Purpose of the Study:
- To explore the potential role of various autoantibodies, particularly anti-receptor antibodies, in the pathophysiology of SSc-mediated organ damage.
- To identify potential therapeutic targets for SSc by understanding the mechanisms of autoantibody-induced tissue damage.
Main Methods:
- Review of existing literature on SSc pathophysiology, autoantibodies, and cell surface receptor signaling.
- Analysis of proposed mechanisms by which antibodies against platelet-derived growth factor, angiotensin II, endothelin A, ICAM-1, and muscarinic receptors may contribute to SSc.
- Consideration of the role of antibodies against CD22 in B-lymphocyte function and autoantibody production.
Main Results:
- Antibodies against cell surface receptors (PDGF, Angiotensin II, Endothelin A, ICAM-1, M3 muscarinic) are hypothesized to play significant roles in SSc symptoms like skin thickening, vasoconstriction, and gastrointestinal dysmotility.
- Antibodies to CD22 may enhance the production of other autoantibodies in SSc patients.
- Laboratory studies suggest plausible signaling pathways for these antibodies' contribution to disease activity, though consensus is lacking.
Conclusions:
- Anti-receptor antibodies, in addition to anti-nuclear antibodies, are potential drivers of SSc organ damage.
- Confirmation of anti-receptor antibody roles and their signaling pathways could revolutionize SSc treatment strategies.
- Future research should focus on epidemiological, mechanistic, and physiological studies to validate these findings and inform therapeutic interventions targeting autoantibodies or their downstream effects.
Related Concept Videos
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
00:42Cross-reactivity
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:27Allergic Drug Reactions